MetLife Investment Management, LLC - CORTEXYME INC ownership

CORTEXYME INC's ticker is CRTX and the CUSIP is 22053A107. A total of 89 filers reported holding CORTEXYME INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CORTEXYME INC
ValueSharesWeighting
Q4 2021$91,015
-86.2%
7,2120.0%0.00%
-83.3%
Q3 2021$661,052
+72.9%
7,2120.0%0.01%
+50.0%
Q2 2021$382,236
+47.1%
7,2120.0%0.00%
+100.0%
Q1 2021$259,848
+29.7%
7,2120.0%0.00%0.0%
Q4 2020$200,349
-44.4%
7,2120.0%0.00%
-50.0%
Q3 2020$360,600
+8.0%
7,2120.0%0.00%0.0%
Q2 2020$333,916
+37.1%
7,212
+35.1%
0.00%
+33.3%
Q1 2020$243,557
-18.8%
5,3400.0%0.00%0.0%
Q4 2019$299,7885,3400.00%
Other shareholders
CORTEXYME INC shareholders Q3 2020
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 3,765,505$199,571,00020.85%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 275,000$14,575,0001.33%
Burleson & Company, LLC 131,130$6,950,0001.02%
Cherry Creek Investment Advisors, Inc. 14,730$781,0000.51%
Intellectus Partners, LLC 33,450$1,773,0000.40%
CSS LLC/IL 125,700$6,662,0000.28%
SG3 Management, LLC 145,000$7,685,0000.27%
COHEN LAWRENCE B 8,997$477,0000.24%
Hennion & Walsh Asset Management, Inc. 81,726$4,331,0000.23%
Alphabet Inc. 189,122$10,023,0000.20%
View complete list of CORTEXYME INC shareholders